2023-08-04 00:00:29 ET
Image source: The Motley Fool.
Gilead Sciences (NASDAQ: GILD)
Q2 2023 Earnings Call
Aug 03, 2023 , 5:00 p.m. ET
Operator
For further details see:
Gilead Sciences (GILD) Q2 2023 Earnings Call Transcript2023-08-04 00:00:29 ET
Image source: The Motley Fool.
Gilead Sciences (NASDAQ: GILD)
Q2 2023 Earnings Call
Aug 03, 2023 , 5:00 p.m. ET
Operator
For further details see:
Gilead Sciences (GILD) Q2 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
– Analysis Comparing Real-World and Clinical Trial Data Show Yescarta ® Has Higher Manufacturing Success Rates and Improved T-Cell Performance, Respectively, in Second-Line vs. Third-Line+ Treatment of Large B-cell Lymphoma – – Encore Oral Present...
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMiD) drug and an anti-CD38 monoclonal antibody -- -- Anito-cel will be manufactured from Kite’s Frederick, Maryland facility for iMMagine-3 as th...